Catalog No.:AA00ANG5

186534-01-0 | Trimethylpyrazine-2-carboxylic acid

Name: Name:Trimethylpyrazine-2-carboxylic acid
Brand: AABLOCKS
SKU: AA00ANG5
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

50mg

95%

3 weeks

$211.00 $148.00

- +

100mg

95%

3 weeks

$258.00 $180.00

- +

250mg

95%

3 weeks

$318.00 $223.00

- +

500mg

95%

3 weeks

$438.00 $307.00

- +

95%

3 weeks

$527.00 $369.00

- +

2.5g

95%

3 weeks

$800.00 $560.00

- +

95%

3 weeks

$1,258.00 $880.00

- +

10g

95%

3 weeks

$2,024.00 $1,417.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA00ANG5

Chemical Name:

Trimethylpyrazine-2-carboxylic acid

CAS Number:

186534-01-0

Molecular Formula:

C8H10N2O2

Molecular Weight:

166.1772

MDL Number:

MFCD18377781

SMILES:

Cc1nc(C(=O)O)c(nc1C)C

Properties

Storage:

Keep in dry area;Room Temperature;

Computed Properties

Complexity:

184

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

0.8

Downstream Synthesis Route

186534-02-1

186534-01-0

[1]Patent:WO2011/105628,2011,A1.Locationinpatent:Page/Pagecolumn78

1124-11-4

186534-01-0

[1]CurrentPatentAssignee:SHENZHENGANLANBIOMEDICALTECH;SHENZHENOLIVEBIOPHARMACEUTICALS-CN111808032,2020,ALocationinpatent:Paragraph0056-0059

[2]CurrentPatentAssignee:GUANGZHOUMAGPIEPHARMACEUTICALS;GUANGZHOUXIQUEMEDICINE;GUANGZHOUMAGPIEPHARMACEUTICAL-US2019/276413,2019,A1Locationinpatent:Paragraph0076-0077

[3]CurrentPatentAssignee:HEFEIUNIVERSITYOFTECHNOLOGY-CN105153049,2017,BLocationinpatent:Paragraph0066-0071

[4]Wang,Yingfei;Zhang,Xiaojing;Xu,Changjiang;Zhang,Gaoxiao;Zhang,Zaijun;Yu,Pei;Shan,Luchen;Sun,Yewei;Wang,Yuqiang[ChemicalandPharmaceuticalBulletin,2017,vol.65,#4,p.381-388]

[5]CurrentPatentAssignee:CHENGDUBAIYUGINKGOLIDEPHARMACEUTICALS-US2019/77811,2019,A1Locationinpatent:Paragraph0043

[6]Abdelgawad,MohamedA.;Al-Sanea,MohammadM.;Alharbi,KhalidSaad;Eldehna,WagdyM.;Elsayed,ZainabM.;Gomaa,HeshamAM.;Gotina,Lizaveta;Mathew,Bijo;Mohamed,MamdouhF.A.;Parambi,DellaGraceThomas;Youssif,BahaaGM.[DrugDesign,DevelopmentandTherapy,2020,vol.14,p.497-508]

[7]Zhang,Chenze;Yan,Wenqiang;Zhao,Rui;Xu,Bing;Fang,Xiong;Yan,Mengmeng;Zhang,Yuzhong;Wang,Penglong;Lei,Haimin[MedChemComm,2017,vol.8,#3,p.652-656]

[8]CurrentPatentAssignee:3DMEDBEIJINGMEDICINETECH-CN106478760,2017,ALocationinpatent:Paragraph0055;0056;0090;0091

[9]Chen,Hongfei;Li,Guoning;Zhan,Peng;Li,Hong;Wang,Shouxun;Liu,Xinyong[MedChemComm,2014,vol.5,#6,p.711-718]

[10]Chen,Haiyun;Tan,Guolian;Cao,Jie;Zhang,Gaoxiao;Yi,Peng;Yu,Pei;Sun,Yewei;Zhang,Zaijun;Wang,Yuqiang[ChemicalandPharmaceuticalBulletin,2017,vol.65,#1,p.56-65]

[11]CurrentPatentAssignee:KPCPHARMACEUTICALS,INC.-CN104341358,2016,BLocationinpatent:Paragraph0059-0062

[12]Lai,Miao;Ji,Xiaoming;Tao,Tao;Shan,Yuanyuan;Liu,Pengfei;Zhao,Mingqin[JournalofThermalAnalysisandCalorimetry,2017,vol.128,#3,p.1627-1638]

[13]CurrentPatentAssignee:UNIVWEIFANGMEDICAL-CN107118166,2017,ALocationinpatent:Paragraph0021;0026;0031;0036

[14]Wu,Gao-Rong;Xu,Bing;Yang,Yu-Qin;Zhang,Xin-Yu;Fang,Kang;Ma,Tao;Wang,Hui;Xue,Nan-Nan;Chen,Meng;Guo,Wen-Bo;Jia,Xiao-Hui;Wang,Peng-Long;Lei,Hai-Min[EuropeanJournalofMedicinalChemistry,2018,vol.155,p.183-196]

[15]Fang,Kang;Zhang,Xiao-Hua;Han,Yao-Tian;Wu,Gao-Rong;Cai,De-Sheng;Xue,Nan-Nan;Guo,Wen-Bo;Yang,Yu-Qin;Chen,Meng;Zhang,Xin-Yu;Wang,Hui;Ma,Tao;Wang,Peng-Long;Lei,Hai-Min[InternationalJournalofMolecularSciences,2018,vol.19,#10]

[16]Wu,Wenhao;Liang,Xintong;Xie,Guoquan;Chen,Langdi;Liu,Weixiong;Luo,Guolin;Zhang,Peiquan;Yu,Lihong;Zheng,Xuehua;Ji,Hong;Zhang,Chao;Yi,Wei[Molecules,2018,vol.23,#10]

[17]Guo,Wen-Bo;Zhang,Hao;Yan,Wen-Qiang;Liu,Yi-Man;Zhou,Fei;Cai,De-Sheng;Zhang,Wen-Xi;Huang,Xue-Mei;Jia,Xiao-Hui;Chen,Hong-Shan;Qi,Jin-Chai;Wang,Peng-Long;Xu,Bing;Lei,Hai-Min[EuropeanJournalofMedicinalChemistry,2020,vol.185]

[18]Wang,Jiawen;Hong,Ge;Li,Guoliang;Wang,Wenzhi;Liu,Tianjun[Molecules,2019,vol.24,#24]

[19]CurrentPatentAssignee:XINHUOZHIYAOBEIJINGTECH-CN110563739,2019,ALocationinpatent:Paragraph0045;0114;0115

[20]Li,Zhenyu;Yu,Fang;Zhan,Peng;Shen,Yuemao;Liu,Xinyong;Cui,Lei;Wang,Shouxun[MedicinalChemistry,2012,vol.8,#5,p.928-933,6]

[21]CurrentPatentAssignee:TIANJINUNIVERSITY-CN113620889,2021,ALocationinpatent:Paragraph0034-0036;0042

498-00-0

186534-01-0

4-(hydroxymethyl)-2-methoxyphenyl3,5,6-trimethylpyrazine-2-carboxylate

[1]CurrentPatentAssignee:LeiPengcheng;ZhangChenze;WangPenglong-CN108456178,2018,ALocationinpatent:Paragraph0122-0124

[2]Zhang,Chenze;Yan,Wenqiang;Zhao,Rui;Xu,Bing;Fang,Xiong;Yan,Mengmeng;Zhang,Yuzhong;Wang,Penglong;Lei,Haimin[MedChemComm,2017,vol.8,#3,p.652-656]

498-00-0

186534-01-0

2-methoxy-4-(((3,5,6-trimethylpyrazine-2-carbonyl)oxy)methyl)phenyl3,5,6-trimethylpyrazine-2-carboxylate

[1]Zhang,Chenze;Yan,Wenqiang;Zhao,Rui;Xu,Bing;Fang,Xiong;Yan,Mengmeng;Zhang,Yuzhong;Wang,Penglong;Lei,Haimin[MedChemComm,2017,vol.8,#3,p.652-656]

[2]CurrentPatentAssignee:LeiPengcheng;ZhangChenze;WangPenglong-CN108456178,2018,ALocationinpatent:Paragraph0134-0136

186534-01-0

696-60-6

N-(4-hydroxybenzyl)-3,5,6-trimethylpyrazine-2-carboxamide

[1]MedChemComm,2017,vol.8,p.652-656

[2]Patent:CN108456178,2018,A.Locationinpatent:Paragraph0078-0080

Literature

Title: Suppression of blood lipid concentrations by volatile Maillard reaction products.

Journal: Nutrition (Burbank, Los Angeles County, Calif.) 20080101

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS